Innovent Biologics grants share options and restricted shares

Innovent Biologics Inc. revealed it has granted 35,000 options to three grantees and 497,750 restricted shares to 25 grantees, who are non-connected employees, according to the company's 2024 Share Scheme. The option grant carries an exercise price of HKD 79.870 per share, with grantees required to pay HKD 1.00 upon acceptance. The options vest in two tranches: 75% on June 30, 2028, and 25% on June 30, 2029, subject to individual performance targets. The market value of the restricted shares is approximately HKD 39,755,292.50.